HIGHLIGHTS
- who: Yuki Sato from the (UNIVERSITY) have published the research work: Development of dermatomyositis after anti-transcriptional intermediary factor 1-u03b3 antibody seroconversion during treatment for small cell lung cancer, in the Journal: (JOURNAL)
SUMMARY
The serum, suggesting a relationship between the antibody and CAM. The mechanism by which TIF1-γ Ab is involved in the pathogenesis of CAM has yet to be clarified. In this report, the authors describe the development of dermatomyositis accompanied by TIF1-γ Ab seroconversion after cancer therapy in a patient with small cell lung cancer. Immunohistochemical analysis demonstrated that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.